Skip to main content

What are you looking for?

Write the name, title or any keyword related to what you are looking for and select which content category it belongs to.

News

A study led by Vall d’Hebron identifies the first case of spontaneous genetic correction in a severe immunodeficiency linked to the Epstein–Barr virus

The paper describes the case of a patient in whom, years after a bone marrow transplant, two immune cell lines corrected the original genetic defect.

News

8000 Estels present a solidarity cheque to the Vall d’Hebron Research Institute to support research

The funds raised will contribute to ensuring the continuity of the pediatric brain tumor research line developed by the Vall d’Hebron research teams.

News

The Vall d’Hebron Accredited Institute secures more than €8 million in the AES 2025 calls of the Carlos III Health Institute

Funding has been obtained for 43 projects under the calls for Health R&D&I Projects, Health Technology Development, and Independent Clinical Research

News

Vall d’Hebron takes part in the European EAST-STROKE project to improve the prevention of recurrent stroke in patients with atrial fibrillation

The study analyzes a new therapeutic strategy in high-risk patients that could influence future international clinical guidelines

Activities

Defensa de Tesi 'Estudi de la resposta immunitària específica front al citomegalovirus humà com a estratègia per a millorar la prevenció i el seguiment dels pacients trasplantats de pulmó'

Doctoranda: Juliana Esperalba Esquerra, del grup de Recerca de Microbiologia. Vall d'Hebron Institut de Recerca (VHIR)Directors: Dr. Andrés Antón Pagarolas i Dr. Óscar Manuel Len AbadTutor: Dr. Tomàs Pumarola Suñé 

News

Vall d'Hebron revalida el seu lideratge en trasplantaments i donació d'òrgans a Catalunya el 2025

Amb 387 procediments practicats, l’Hospital Vall d’Hebron es consolida al capdavant dels centres capacitats per realitzar trasplantaments en adults i pediàtrics.

News

An international study sheds light on the mechanism through which metabolites guide cellular decisions

The report, published in Nature, reveals that polyamines bind to specific domains in proteins and operate as a metabolic shield against modifications in their structure.

News

The pre-registration for the VHIR master’s programs is now open

You can now pre-register for the Master’s Degree in Translational Biomedical Research, the Master’s in Health Innovation and Entrepreneurship, and the Master’s in Clinical Trials Management and Coordination.

News

Vall Hebron hosts the annual meeting of the international IEI-Haem project on inborn errors of immunity in patients with hematological diseases

During the annual meeting, representatives from the different centers participating in the project shared the progress status of the various areas of work.

Activities

Xerrada 70 Anys

La xerrada se centrarà especialment en com la recerca permet desenvolupar nous fàrmacs i teràpies per a infants i adolescents amb càncer, explicant el procés que va del laboratori a la pràctica clínica. Posant en valor l'impacte directe que la investigació té en els pacients d'avui i en les opcio

Activities

Recerca en oncologia pediàtrica

Participant: Dr. Lucas Moreno, Cap de grup de càncer i malalties hematològiques infantil del Vall d’Hebron Institut de Recerca (VHIR) i cap del Servei d'Oncologia i Hematologia Pediàtrica de Vall d’Hebron.La xerrada se centrarà especialment en com la recerca permet desenvo

Activities

Recerca en medicina maternal i fetal

Aquesta xerrada farà un viatge per l’evolució de la medicina maternofetal, des dels parts d’abans de l’edat mitjana fins als grans avenços que han canviat completament la manera de cuidar mares i nadons. Descobrirem com va néixer la Medicina Fetal —quan el fetus passa a ser un pacient— i com això

News

A Vall d’Hebron doctoral thesis wins the CERCA Pioner Award

The project has developed a low-cost system to diagnose malaria and schistosomiasis using artificial intelligence and a robotic microscope.

News

Vall d’Hebron and Hipofam celebrate ten years of advancing research on an ultra-rare kidney disease

The collaboration between the Vall d’Hebron Research Institute (VHIR) and the Association for Information and Research on Familial Hypomagnesemia (Hipofam) celebrates ten years.

News

Vall d’Hebron and Hipofam promote a project to create new models to study a rare kidney disease

The aim of the project is to establish kidney organoids derived from patients with familial hypomagnesaemia with hypercalciuria and nephrocalcinosis, which will be essential tools for studying the disease and testing new treatments.

Activities

Defensa de Tesi 'Estudi de les seqüeles a mitjà i llarg termini de la traqueostomia percutània a la fonació, deglució i respiració'

Doctoranda: María de las Nieves Pelay Panes, Grup de Recerca Multidisciplinari d'infermeria. Vall d'Hebron Institut de Recerca (VHIR)Direcctors: Dr. Juan Lorente Guerrero i Dra. Esperanza Zuriguel Pérez.Tutor: Dr. Juan Lorente Guerrero 

Activities

Defensa de Tesi 'Estudi de les seqüeles a mitjà i llarg termini de la traqueostomia percutània a la fonació, deglució i respiració'

Doctoranda: María de las Nieves Pelay Panes, Grup de Recerca Multidisciplinari d'infermeria. Vall d'Hebron Institut de Recerca (VHIR)Direcctors: Dr. Juan Lorente Guerrero i Dra. Esperanza Zuriguel Pérez.Tutor: Dr. Juan Lorente Guerrero

News

The European registry of rare anemias RADeep currently includes over 5,000 patients registered across nine countries

2025 has been an active year with the participation of RADeep members at the Data Access Committee at Vall d’Hebron and the presentation of abstracts at the 67th ASH Annual Meeting and Exposition.

Activities

Retiment de Comptes de l'Hospital Universitari de Vall d'Hebron

El pròxim dimecres  17 de desembre, a les 13.00 hores, tindrà lloc a la sala d'actes del Pavelló Docent el retiment de comptes de l'Hospital Universitari Vall d'Hebron. De la mà del Dr. Albert Salazar, gerent de l'Hospital, es farà un